Phase Ib trial of a targeted TLR9 CpG immunomodulator (CPG 7909) in advanced renal cell carcinoma (RCC)

Abstract only

Saved in:
Bibliographic Details
Published inJournal of clinical oncology Vol. 22; no. 14_suppl; p. 4644
Main Authors Thompson, J. A., Kuzel, T., Bukowski, R., Masciari, F., Schmalbach, T.
Format Journal Article
LanguageEnglish
Published 15.07.2004
Online AccessGet full text

Cover

More Information
Summary:Abstract only
ISSN:0732-183X
1527-7755
DOI:10.1200/jco.2004.22.14_suppl.4644